Number of Affected Nails Is the Primary Determinant of Efinaconazole 10% Solution Usage for Onychomycosis

February 2024 | Volume 23 | Issue 2 | 110 | Copyright © February 2024


Published online January 20, 2024

Steven R. Feldman MD PhDa, Tracey C. Vlahovic DPMb, Warren S. Joseph DPMc, C. Ralph Daniel MDd, Boni Elewski MDe, Phoebe Rich MDf, Shari R. Lipner MD PhDg

aWake Forest School of Medicine, Winston-Salem, NC 
bTemple University School of Podiatric Medicine, Philadelphia, PA 
cArizona College of Podiatric Medicine, Midwestern University, Glendale, AZ 
dUniversity of Mississippi Medical Center, Jackson, MS 
eUniversity of Alabama at Birmingham School of Medicine, Birmingham, AL 
fOregon Health and Science University, Portland, OR 
gWeill Cornell Medicine, New York, NY


1.17 to 1.32 4 mL bottles monthly (Figure 2). Because application instructions specify that the nail plate, toenail folds, toenail bed, hyponychium, and nail plate undersurface should be completely covered, regardless of the area of involvement, it was expected that medication usage might be similar for nails with different surface areas affected.5 

DISCUSSION

In these clinical trials, participants were provided 10 mL of efinaconazole per month. In clinical practice, however, almost 90% of prescriptions for efinaconazole are for one 4 mL bottle monthly.3 For patients with 2 or more affected toenails, a 4 mL bottle would likely be depleted in under a month, and after as few as 19 days with 6 affected nails, leaving treatment gaps until prescriptions are refilled. Because intermittent treatment may affect medication efficacy and increase the likelihood of relapse or reinfection,1 patients with more than one nail involved might be more likely to achieve success with an 8 mL bottle of efinaconazole (Figure 3). Given that nail percent involvement, sex, and BMI do not affect medication usage, number of affected nails should be the major consideration when determining the monthly efinaconazole quantity to prescribe.